Yahoo Finance

Bio-Matrix Scientific Group Provides Update on Its Regen BioPharma's HemaXellerate I(TM) Clinical Program

SAN DIEGO, CA--(Marketwired - Jul 31, 2013) - Bio-Matrix Scientific Group Inc. (OTCQB: BMSN) provided an update today on its subsidiary, Regen BioPharma's Investigational New Drug (IND) application ...
technologynetworks

Bio-Matrix Scientific Enters into Contract with Validation Systems

Bio-Matrix Scientific Group Inc. has announced it has entered into a contract with Validation Systems, Inc. to complete and finalize its FDA Good Manufacturing Practices (cGMP) Quality Systems ...
Yahoo Finance

Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders

SAN DIEGO, CA--(Marketwired - Oct 9, 2013) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) today announced that its Board of Directors has authorized a distribution on a pro rata basis as a dividend ...
FierceBiotech

Bio-Matrix Scientific Group and Entest BioMedical Finalizes New Immuno-therapeutic Cancer Vaccine Joint Venture with Therinject

SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) and Its majority owned subsidiary Entest BioMedical Inc. (OTCBB: ENTB) announced today they have finalized a definitive ...